Mechanism of and requirement for estrogen-regulated MYB expression in estrogen-receptor-positive breast cancer cells
Date
2007
Authors
Drabsch, Y.
Hugo, H.
Zhang, R.
Dowhan, D.
Miao, Y.
Gewirtz, A.
Barry, S.
Ramsay, R.
Gonda, T.
Editors
Advisors
Journal Title
Journal ISSN
Volume Title
Type:
Journal article
Citation
Proceedings of the National Academy of Sciences of USA, 2007; 104(34):13762-13767
Statement of Responsibility
Yvette Drabsch, Honor Hugo, Rui Zhang, Dennis H. Dowhan, Yu Rebecca Miao, Alan M. Gewirtz, Simon C. Barry, Robert G. Ramsay, and Thomas J. Gonda
Conference Name
Abstract
MYB (the human ortholog of c-myb) is expressed in a high proportion of human breast tumors, and that expression correlates strongly with estrogen receptor (ER) positivity. This may reflect the fact that MYB is a target of estrogen/ER signaling. Because in many cases MYB expression appears to be regulated by transcriptional attenuation or pausing in the first intron, we first investigated whether this mechanism was involved in estrogen/ER modulation of MYB. We found that this was the case and that estrogen acted directly to relieve attenuation due to sequences within the first intron, specifically, a region potentially capable of forming a stem–loop structure in the transcript and an adjacent poly(dT) tract. Secondly, given the involvement of MYB in hematopoietic and colon tumors, we also asked whether MYB was required for the proliferation of breast cancer cells. We found that proliferation of ER+ but not ER- breast cancer cell lines was inhibited when MYB expression was suppressed by using either antisense oligonucleotides or RNA interference. Our results show that MYB is an effector of estrogen/ER signaling and provide demonstration of a functional role of MYB in breast cancer.
School/Discipline
Dissertation Note
Provenance
Description
Copyright © 2007 by the National Academy of Sciences